Showing results (1621-1630 of 1,800) with videos related to

Sort By:
Pageof 180
Gastroenterology|August 31, 2016
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular CarcinomaRiad Salem, Andrew C Gordon, Samdeep Mouli, et al.
JAMA|February 13, 2020
Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension: A Randomized Clinical TrialFrançois Lamontagne, Alvin Richards-Belle, Karen Thomas, et al.
The Lancet. Respiratory Medicine|August 31, 2020
Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational studyPratik Sinha, Carolyn S Calfee, Shiney Cherian, et al.
Rheumatology (Oxford, England)|March 11, 2005
The systemic lupus erythematosus tri-nation study: longitudinal changes in physical and mental well-beingP Panopalis, M Petri, S Manzi, et al.
Health Technology Assessment (Winchester, England)|March 2, 2021
Reduced exposure to vasopressors through permissive hypotension to reduce mortality in critically ill people aged 65 and over: the 65 RCTPaul R Mouncey, Alvin Richards-Belle, Karen Thomas, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 14, 2021
Radiotherapy Quality Assurance in the PORTEC-3 (TROG 08.04) TrialP Khaw, V Do, K Lim, et al.
Hepatology (Baltimore, Md.)|January 28, 2017
Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct-acting antiviral treatmentFred Poordad, Franco Felizarta, Armen Asatryan, et al.
American Heart Journal|March 29, 2008
Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis eventsMichael J Rinaldi, Ajay J Kirtane, Robert N Piana, et al.
Alimentary Pharmacology & Therapeutics|May 29, 2013
Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirinS C Gordon, E M Yoshida, E J Lawitz, et al.
Gastroenterology|December 16, 2014
Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acidGideon M Hirschfield, Andrew Mason, Velimir Luketic, et al.
Pageof 180